Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 174 Pages
Report ld: 5344282
Request Sample
Customized Report
PTA Balloon Dilatation Catheters Market Size(US$)

CAGR 2025-2031
6.8%
Market Size,2031
USD 4,093
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global PTA Balloon Dilatation Catheters market is projected to grow from US$ 2599 million in 2024 to US$ 4093 million by 2031, at a CAGR of 6.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
PTA Balloon Dilatation Catheter is a Percutaneous Transluminal Angioplasty (PTA) balloon dilatation catheter for peripheral indications
The PTA Dilation Catheters are non-reusable semi-compliant coaxial design catheters consisting of an over the wire (OTW) catheter with a balloon mounted on its distal tip.
The PTA (Percutaneous Transluminal Angioplasty) dilation catheters market is driven by various factors that contribute to the adoption and growth of these specialized medical devices. Some key drivers include:
Prevalence of Peripheral Artery Disease: The increasing prevalence of peripheral artery disease (PAD) drives the demand for effective treatment options. PTA dilation catheters are a critical tool in the management of arterial blockages in peripheral arteries.
Minimally Invasive Procedures: PTA dilation catheters enable minimally invasive procedures to treat arterial stenosis or blockages. Patients and healthcare providers prefer minimally invasive options due to shorter recovery times, reduced complications, and faster return to normal activities.
Aging Population: As the global population ages, the incidence of peripheral artery disease tends to increase. Older adults are more susceptible to PAD and may require interventions like angioplasty to restore blood flow in affected arteries.
Advancements in Technology: Ongoing advancements in catheter design, balloon materials, and catheter coatings have improved the performance and safety of PTA dilation catheters. These advancements enhance their effectiveness in treating complex lesions and challenging anatomies.
Growing Demand for Non-Surgical Options: PTA dilation catheters offer a non-surgical option to address peripheral arterial blockages, reducing the need for open surgery and its associated risks.
Demand for Immediate Results: PTA dilation catheters provide rapid restoration of blood flow, leading to immediate symptom relief, improved limb function, and enhanced patient outcomes.
Rising Healthcare Expenditure: Increasing healthcare spending globally, especially in emerging economies, contributes to the adoption of advanced medical technologies like PTA dilation catheters.
Patient Awareness and Education: Patients are becoming more informed about peripheral artery disease and its treatment options. They may actively seek interventions like angioplasty to alleviate symptoms and improve their quality of life.
Market Competition: Competition among medical device manufacturers drives innovation in PTA dilation catheter design, leading to improved performance, ease of use, and patient outcomes.
Technological Innovations: New technologies, such as drug-coated balloons and specialty catheters for specific anatomies, contribute to the expansion of the PTA dilation catheters market.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global PTA Balloon Dilatation Catheters market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the PTA Balloon Dilatation Catheters study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to PTA Balloon Dilatation Catheters: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global PTA Balloon Dilatation Catheters Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Rated Burst Pressure 10 Atm Below
1.2.3 Rated Burst Pressure 10-20 Atm
1.2.4 Rated Burst Pressure 20-30 Atm
1.2.5 Rated Burst Pressure 30 Atm Above
1.3 Market Segmentation by Application
1.3.1 Global PTA Balloon Dilatation Catheters Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Medical Research Institute
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global PTA Balloon Dilatation Catheters Revenue Estimates and Forecasts 2020-2031
2.2 Global PTA Balloon Dilatation Catheters Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global PTA Balloon Dilatation Catheters Sales Estimates and Forecasts 2020-2031
2.4 Global PTA Balloon Dilatation Catheters Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global PTA Balloon Dilatation Catheters Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global PTA Balloon Dilatation Catheters Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Rated Burst Pressure 10 Atm Below Market Size by Manufacturers
3.5.2 Rated Burst Pressure 10-20 Atm Market Size by Manufacturers
3.5.3 Rated Burst Pressure 20-30 Atm Market Size by Manufacturers
3.5.4 Rated Burst Pressure 30 Atm Above Market Size by Manufacturers
3.6 Global PTA Balloon Dilatation Catheters Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global PTA Balloon Dilatation Catheters Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global PTA Balloon Dilatation Catheters Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global PTA Balloon Dilatation Catheters Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global PTA Balloon Dilatation Catheters Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America PTA Balloon Dilatation Catheters Sales and Revenue by Type (2020-2031)
6.4 North America PTA Balloon Dilatation Catheters Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America PTA Balloon Dilatation Catheters Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe PTA Balloon Dilatation Catheters Sales and Revenue by Type (2020-2031)
7.4 Europe PTA Balloon Dilatation Catheters Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe PTA Balloon Dilatation Catheters Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific PTA Balloon Dilatation Catheters Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific PTA Balloon Dilatation Catheters Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific PTA Balloon Dilatation Catheters Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America PTA Balloon Dilatation Catheters Sales and Revenue by Type (2020-2031)
9.4 Central and South America PTA Balloon Dilatation Catheters Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America PTA Balloon Dilatation Catheters Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa PTA Balloon Dilatation Catheters Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa PTA Balloon Dilatation Catheters Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa PTA Balloon Dilatation Catheters Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Terumo
11.1.1 Terumo Corporation Information
11.1.2 Terumo Business Overview
11.1.3 Terumo PTA Balloon Dilatation Catheters Product Models, Descriptions and Specifications
11.1.4 Terumo PTA Balloon Dilatation Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Terumo PTA Balloon Dilatation Catheters Sales by Product in 2024
11.1.6 Terumo PTA Balloon Dilatation Catheters Sales by Application in 2024
11.1.7 Terumo PTA Balloon Dilatation Catheters Sales by Geographic Area in 2024
11.1.8 Terumo PTA Balloon Dilatation Catheters SWOT Analysis
11.1.9 Terumo Recent Developments
11.2 Medtronic
11.2.1 Medtronic Corporation Information
11.2.2 Medtronic Business Overview
11.2.3 Medtronic PTA Balloon Dilatation Catheters Product Models, Descriptions and Specifications
11.2.4 Medtronic PTA Balloon Dilatation Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Medtronic PTA Balloon Dilatation Catheters Sales by Product in 2024
11.2.6 Medtronic PTA Balloon Dilatation Catheters Sales by Application in 2024
11.2.7 Medtronic PTA Balloon Dilatation Catheters Sales by Geographic Area in 2024
11.2.8 Medtronic PTA Balloon Dilatation Catheters SWOT Analysis
11.2.9 Medtronic Recent Developments
11.3 Abbott
11.3.1 Abbott Corporation Information
11.3.2 Abbott Business Overview
11.3.3 Abbott PTA Balloon Dilatation Catheters Product Models, Descriptions and Specifications
11.3.4 Abbott PTA Balloon Dilatation Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Abbott PTA Balloon Dilatation Catheters Sales by Product in 2024
11.3.6 Abbott PTA Balloon Dilatation Catheters Sales by Application in 2024
11.3.7 Abbott PTA Balloon Dilatation Catheters Sales by Geographic Area in 2024
11.3.8 Abbott PTA Balloon Dilatation Catheters SWOT Analysis
11.3.9 Abbott Recent Developments
11.4 Boston Scientific
11.4.1 Boston Scientific Corporation Information
11.4.2 Boston Scientific Business Overview
11.4.3 Boston Scientific PTA Balloon Dilatation Catheters Product Models, Descriptions and Specifications
11.4.4 Boston Scientific PTA Balloon Dilatation Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Boston Scientific PTA Balloon Dilatation Catheters Sales by Product in 2024
11.4.6 Boston Scientific PTA Balloon Dilatation Catheters Sales by Application in 2024
11.4.7 Boston Scientific PTA Balloon Dilatation Catheters Sales by Geographic Area in 2024
11.4.8 Boston Scientific PTA Balloon Dilatation Catheters SWOT Analysis
11.4.9 Boston Scientific Recent Developments
11.5 Merit Medical Systems
11.5.1 Merit Medical Systems Corporation Information
11.5.2 Merit Medical Systems Business Overview
11.5.3 Merit Medical Systems PTA Balloon Dilatation Catheters Product Models, Descriptions and Specifications
11.5.4 Merit Medical Systems PTA Balloon Dilatation Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Merit Medical Systems PTA Balloon Dilatation Catheters Sales by Product in 2024
11.5.6 Merit Medical Systems PTA Balloon Dilatation Catheters Sales by Application in 2024
11.5.7 Merit Medical Systems PTA Balloon Dilatation Catheters Sales by Geographic Area in 2024
11.5.8 Merit Medical Systems PTA Balloon Dilatation Catheters SWOT Analysis
11.5.9 Merit Medical Systems Recent Developments
11.6 Biotronik
11.6.1 Biotronik Corporation Information
11.6.2 Biotronik Business Overview
11.6.3 Biotronik PTA Balloon Dilatation Catheters Product Models, Descriptions and Specifications
11.6.4 Biotronik PTA Balloon Dilatation Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Biotronik Recent Developments
11.7 B. Braun
11.7.1 B. Braun Corporation Information
11.7.2 B. Braun Business Overview
11.7.3 B. Braun PTA Balloon Dilatation Catheters Product Models, Descriptions and Specifications
11.7.4 B. Braun PTA Balloon Dilatation Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 B. Braun Recent Developments
11.8 Cordis
11.8.1 Cordis Corporation Information
11.8.2 Cordis Business Overview
11.8.3 Cordis PTA Balloon Dilatation Catheters Product Models, Descriptions and Specifications
11.8.4 Cordis PTA Balloon Dilatation Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Cordis Recent Developments
11.9 BD
11.9.1 BD Corporation Information
11.9.2 BD Business Overview
11.9.3 BD PTA Balloon Dilatation Catheters Product Models, Descriptions and Specifications
11.9.4 BD PTA Balloon Dilatation Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 BD Recent Developments
11.10 Cook Medical
11.10.1 Cook Medical Corporation Information
11.10.2 Cook Medical Business Overview
11.10.3 Cook Medical PTA Balloon Dilatation Catheters Product Models, Descriptions and Specifications
11.10.4 Cook Medical PTA Balloon Dilatation Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Cook Medical Recent Developments
11.11 OrbusNeich
11.11.1 OrbusNeich Corporation Information
11.11.2 OrbusNeich Business Overview
11.11.3 OrbusNeich PTA Balloon Dilatation Catheters Product Models, Descriptions and Specifications
11.11.4 OrbusNeich PTA Balloon Dilatation Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 OrbusNeich Recent Developments
11.12 Natec Medical
11.12.1 Natec Medical Corporation Information
11.12.2 Natec Medical Business Overview
11.12.3 Natec Medical PTA Balloon Dilatation Catheters Product Models, Descriptions and Specifications
11.12.4 Natec Medical PTA Balloon Dilatation Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Natec Medical Recent Developments
11.13 Nipro
11.13.1 Nipro Corporation Information
11.13.2 Nipro Business Overview
11.13.3 Nipro PTA Balloon Dilatation Catheters Product Models, Descriptions and Specifications
11.13.4 Nipro PTA Balloon Dilatation Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Nipro Recent Developments
11.14 Philips
11.14.1 Philips Corporation Information
11.14.2 Philips Business Overview
11.14.3 Philips PTA Balloon Dilatation Catheters Product Models, Descriptions and Specifications
11.14.4 Philips PTA Balloon Dilatation Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Philips Recent Developments
11.15 Surmodics
11.15.1 Surmodics Corporation Information
11.15.2 Surmodics Business Overview
11.15.3 Surmodics PTA Balloon Dilatation Catheters Product Models, Descriptions and Specifications
11.15.4 Surmodics PTA Balloon Dilatation Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Surmodics Recent Developments
11.16 Meril Life
11.16.1 Meril Life Corporation Information
11.16.2 Meril Life Business Overview
11.16.3 Meril Life PTA Balloon Dilatation Catheters Product Models, Descriptions and Specifications
11.16.4 Meril Life PTA Balloon Dilatation Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 Meril Life Recent Developments
11.17 Lepu Medical Technology
11.17.1 Lepu Medical Technology Corporation Information
11.17.2 Lepu Medical Technology Business Overview
11.17.3 Lepu Medical Technology PTA Balloon Dilatation Catheters Product Models, Descriptions and Specifications
11.17.4 Lepu Medical Technology PTA Balloon Dilatation Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Lepu Medical Technology Recent Developments
11.18 ZYLOX-TONBRIDGE
11.18.1 ZYLOX-TONBRIDGE Corporation Information
11.18.2 ZYLOX-TONBRIDGE Business Overview
11.18.3 ZYLOX-TONBRIDGE PTA Balloon Dilatation Catheters Product Models, Descriptions and Specifications
11.18.4 ZYLOX-TONBRIDGE PTA Balloon Dilatation Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 ZYLOX-TONBRIDGE Recent Developments
11.19 BIOTEQUE
11.19.1 BIOTEQUE Corporation Information
11.19.2 BIOTEQUE Business Overview
11.19.3 BIOTEQUE PTA Balloon Dilatation Catheters Product Models, Descriptions and Specifications
11.19.4 BIOTEQUE PTA Balloon Dilatation Catheters Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 BIOTEQUE Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 PTA Balloon Dilatation Catheters Industry Chain
12.2 PTA Balloon Dilatation Catheters Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 PTA Balloon Dilatation Catheters Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 PTA Balloon Dilatation Catheters Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 PTA Balloon Dilatation Catheters Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global PTA Balloon Dilatation Catheters Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for PTA Balloon Dilatation Catheters was estimated to be worth US$ 2758 million in 2025 and is projected to reach US$ 4344 million, growing at a CAGR of 6.8% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 149
USD 3950.00
(Single User License)
The global PTA Balloon Dilatation Catheters market was valued at US$ 2758 million in 2025 and is anticipated to reach US$ 4344 million by 2032, at a CAGR of 6.8% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 129
USD 2900.00
(Single User License)
The global PTA Balloon Dilatation Catheters market size was US$ 2599 million in 2024 and is forecast to a readjusted size of US$ 4093 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 105
USD 4250.00
(Single User License)
The global market for PTA Balloon Dilatation Catheters was estimated to be worth US$ 2599 million in 2024 and is forecast to a readjusted size of US$ 4093 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 132
USD 3950.00
(Single User License)
The global market for PTA Balloon Dilatation Catheters was valued at US$ 2599 million in the year 2024 and is projected to reach a revised size of US$ 4093 million by 2031, growing at a CAGR of 6.8% during the forecast period.
Published Date: 2025-01-13
Pages: 105
USD 2900.00
(Single User License)
PTA Balloon Dilatation Catheter is a Percutaneous Transluminal Angioplasty (PTA) balloon dilatation catheter for peripheral indications
Published Date: 2024-04-28
Pages: 117
USD 4900.00
(Single User License)
PTA Balloon Dilatation Catheter is a Percutaneous Transluminal Angioplasty (PTA) balloon dilatation catheter for peripheral indications
Published Date: 2024-02-05
Pages: 104
USD 2900.00
(Single User License)
The global market for PTA Balloon Dilatation Catheters was estimated to be worth US$ 2758 million in 2025 and is projected to reach US$ 4344 million, growing at a CAGR of 6.8% from 2026 to 2032.
Published: 2026-06-16
Pages: 149
The global PTA Balloon Dilatation Catheters market was valued at US$ 2758 million in 2025 and is anticipated to reach US$ 4344 million by 2032, at a CAGR of 6.8% from 2026 to 2032.
Published: 2026-04-17
Pages: 129
The global PTA Balloon Dilatation Catheters market size was US$ 2599 million in 2024 and is forecast to a readjusted size of US$ 4093 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 105
The global market for PTA Balloon Dilatation Catheters was estimated to be worth US$ 2599 million in 2024 and is forecast to a readjusted size of US$ 4093 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 132
The global market for PTA Balloon Dilatation Catheters was valued at US$ 2599 million in the year 2024 and is projected to reach a revised size of US$ 4093 million by 2031, growing at a CAGR of 6.8% during the forecast period.
Published: 2025-01-13
Pages: 105
PTA Balloon Dilatation Catheter is a Percutaneous Transluminal Angioplasty (PTA) balloon dilatation catheter for peripheral indications
Published: 2024-04-28
Pages: 117
PTA Balloon Dilatation Catheter is a Percutaneous Transluminal Angioplasty (PTA) balloon dilatation catheter for peripheral indications
Published: 2024-02-05
Pages: 104
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now